Transactivation of EGFR by cognate ligands such as epidermal growth factor (EGF) promotes NSCLC cell proliferation through PPD and SH3 domain interaction and eventually induces a downstream cascade such as MAPK signaling [19]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.